Correlation Between Brooklyn Immunotherapeuti and Moleculin Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brooklyn Immunotherapeuti and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brooklyn Immunotherapeuti and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brooklyn Immunotherapeutics and Moleculin Biotech, you can compare the effects of market volatilities on Brooklyn Immunotherapeuti and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brooklyn Immunotherapeuti with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brooklyn Immunotherapeuti and Moleculin Biotech.

Diversification Opportunities for Brooklyn Immunotherapeuti and Moleculin Biotech

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Brooklyn and Moleculin is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Brooklyn Immunotherapeutics and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Brooklyn Immunotherapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brooklyn Immunotherapeutics are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Brooklyn Immunotherapeuti i.e., Brooklyn Immunotherapeuti and Moleculin Biotech go up and down completely randomly.

Pair Corralation between Brooklyn Immunotherapeuti and Moleculin Biotech

If you would invest  21.00  in Brooklyn Immunotherapeutics on December 29, 2023 and sell it today you would earn a total of  0.00  from holding Brooklyn Immunotherapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.55%
ValuesDaily Returns

Brooklyn Immunotherapeutics  vs.  Moleculin Biotech

 Performance 
       Timeline  
Brooklyn Immunotherapeuti 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Brooklyn Immunotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Brooklyn Immunotherapeuti is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Moleculin Biotech 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Moleculin Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Brooklyn Immunotherapeuti and Moleculin Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brooklyn Immunotherapeuti and Moleculin Biotech

The main advantage of trading using opposite Brooklyn Immunotherapeuti and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brooklyn Immunotherapeuti position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.
The idea behind Brooklyn Immunotherapeutics and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.